It said it would acquire Guangzhou Bioseal Biotechnology Co Ltd, a bio-pharmaceutical company developing a biologic product for controlling bleeding during surgery.

FORBES: Humanwell Healthcare Shows Consolidation Is Hot in China's Health Care